Logo image of NAVA.OL

NAVAMEDIC (NAVA.OL) Stock Price, Quote, News and Overview

OSL:NAVA - Euronext Oslo - NO0010205966 - Common Stock - Currency: NOK

21.8  -0.1 (-0.46%)

NAVA.OL Quote, Performance and Key Statistics

NAVAMEDIC

OSL:NAVA (5/28/2025, 7:00:00 PM)

21.8

-0.1 (-0.46%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High35
52 Week Low17.1
Market Cap384.99M
Shares17.66M
Float8.46M
Yearly DividendN/A
Dividend YieldN/A
PE311.43
Fwd PE29.48
Earnings (Next)N/A N/A
IPO03-31 2006-03-31


NAVA.OL short term performance overview.The bars show the price performance of NAVA.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10

NAVA.OL long term performance overview.The bars show the price performance of NAVA.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of NAVA.OL is 21.8 NOK. In the past month the price increased by 0.93%. In the past year, price decreased by -35.69%.

NAVAMEDIC / NAVA Daily stock chart

NAVA.OL Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1LLY.MI ELI LILLY & CO 52.44 604.37B
LLY.DE ELI LILLY & CO 52.35 603.33B
ZEG.DE ASTRAZENECA PLC 16.09 385.22B
1JNJ.MI JOHNSON & JOHNSON 15.18 324.34B
JNJ.DE JOHNSON & JOHNSON 15.16 323.81B
NOV.DE NOVO NORDISK A/S-B 19.27 269.71B
RHO.DE ROCHE HOLDING AG-BR 14.76 239.86B
1SAN.MI SANOFI 12.22 228.72B
SNW.DE SANOFI 12.04 225.36B
SAN.PA SANOFI 11.96 223.83B
NOT.DE NOVARTIS AG-REG 13.56 196.32B
1MRKX.MI MERCK & CO. INC. 9.94 171.75B

About NAVA.OL

Company Profile

NAVA logo image Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo and currently employs 45 full-time employees. The company went IPO on 2006-03-31. The company is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The firm has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The firm has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.

Company Info

NAVAMEDIC

Henrik Ibsens gate 100

Oslo OSLO NO

Employees: 45

NAVA Company Website

NAVA Investor Relations

Phone: 4767112540

NAVAMEDIC / NAVA.OL FAQ

What is the stock price of NAVAMEDIC today?

The current stock price of NAVA.OL is 21.8 NOK. The price decreased by -0.46% in the last trading session.


What is the ticker symbol for NAVAMEDIC stock?

The exchange symbol of NAVAMEDIC is NAVA and it is listed on the Euronext Oslo exchange.


On which exchange is NAVA.OL stock listed?

NAVA.OL stock is listed on the Euronext Oslo exchange.


What is the price forecast or stock price prediction for NAVAMEDIC stock?

8 analysts have analysed NAVA.OL and the average price target is 32.64 NOK. This implies a price increase of 49.72% is expected in the next year compared to the current price of 21.8. Check the NAVAMEDIC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is NAVAMEDIC worth?

NAVAMEDIC (NAVA.OL) has a market capitalization of 384.99M NOK. This makes NAVA.OL a Small Cap stock.


How many employees does NAVAMEDIC have?

NAVAMEDIC (NAVA.OL) currently has 45 employees.


What are the support and resistance levels for NAVAMEDIC (NAVA.OL) stock?

NAVAMEDIC (NAVA.OL) has a support level at 21.76 and a resistance level at 22.61. Check the full technical report for a detailed analysis of NAVA.OL support and resistance levels.


Is NAVAMEDIC (NAVA.OL) expected to grow?

The Revenue of NAVAMEDIC (NAVA.OL) is expected to grow by 9.98% in the next year. Check the estimates tab for more information on the NAVA.OL EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy NAVAMEDIC (NAVA.OL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NAVAMEDIC (NAVA.OL) stock pay dividends?

NAVA.OL does not pay a dividend.


What is the Price/Earnings (PE) ratio of NAVAMEDIC (NAVA.OL)?

The PE ratio for NAVAMEDIC (NAVA.OL) is 311.43. This is based on the reported non-GAAP earnings per share of 0.07 and the current share price of 21.8 NOK. Check the full fundamental report for a full analysis of the valuation metrics for NAVA.OL.


NAVA.OL Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to NAVA.OL. When comparing the yearly performance of all stocks, NAVA.OL is a bad performer in the overall market: 82.74% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

NAVA.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to NAVA.OL. NAVA.OL may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NAVA.OL Financial Highlights

Over the last trailing twelve months NAVA.OL reported a non-GAAP Earnings per Share(EPS) of 0.07. The EPS decreased by -62.23% compared to the year before.


Industry RankSector Rank
PM (TTM) 0.24%
ROA 0.26%
ROE 0.54%
Debt/Equity 0.33
Chartmill High Growth Momentum
EPS Q2Q%-2161.58%
Sales Q2Q%4.7%
EPS 1Y (TTM)-62.23%
Revenue 1Y (TTM)3.8%

NAVA.OL Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to NAVA.OL. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of -43.8% and a revenue growth 9.98% for NAVA.OL


Ownership
Inst Owners36.11%
Ins Owners19.89%
Short Float %N/A
Short RatioN/A
Analysts
Analysts82.5
Price Target32.64 (49.72%)
EPS Next Y-43.8%
Revenue Next Year9.98%